SCHEMBL7365950

SCHEMBL7365950

CCCc1ccc(CC[C@H](CCC(=O)O)C(=O)O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.54
MMP2 P08253 2/20 0.53
MMP3 P08254 2/20 0.53
S1PR2 O95136 1/20 0.52
S1PR1 P21453 1/20 0.52
S1PR3 Q99500 1/20 0.52
CPA3 P15088 1/20 0.51
FOLH1 Q04609 4/20 0.46
LMNA P02545 1/20 0.44
CHRM1 P11229 1/20 0.44
AKR1A1 P14550 1/20 0.44
CHRM3 P20309 1/20 0.44
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44
ADRA1A P35348 1/20 0.44
HRH1 P35367 1/20 0.44
DRD3 P35462 1/20 0.44
SLC6A3 Q01959 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7386705 1.00 L3MBTL1 (0.54) L3MBTL1MMP2MMP3S1PR2S1PR1
SCHEMBL7427004 1.00 L3MBTL1 (0.54) L3MBTL1MMP2MMP3S1PR2S1PR1
SCHEMBL7419061 0.90 MMP2 (0.48) L3MBTL1MMP2MMP3S1PR2S1PR1
SCHEMBL7375728 0.88 S1PR2 (0.49) L3MBTL1MMP2MMP3S1PR2S1PR1
SCHEMBL7385943 0.88 S1PR2 (0.49) L3MBTL1MMP2MMP3S1PR2S1PR1
SCHEMBL21895810 0.85 MMP2 (0.61) MMP2MMP3S1PR2S1PR1
SCHEMBL7382744 0.84 MMP2 (0.55) L3MBTL1MMP2MMP3S1PR2S1PR1
SCHEMBL7362919 0.84 MMP2 (0.55) L3MBTL1MMP2MMP3S1PR2S1PR1
SCHEMBL7350860 0.84 CPA3 (0.71) MMP3CPA3FOLH1ADRA1ASLC6A3
SCHEMBL7422139 0.83 MMP3 (0.47) L3MBTL1MMP2MMP3S1PR2S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3060573-A1 TETRAPEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME Kaneka Corporation (JP) 2016-08-31 EP disclosed
WO-2015060462-A1 TETRAPEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME KANEKA CORPORATION (JP) 2015-04-30 WO disclosed
EP-1098662-A2 COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS WARNER-LAMBERT COMPANY (US) 2001-05-16 EP disclosed
EP-1047450-A1 ACE INHIBITOR-MMP INHIBITOR COMBINATIONS WARNER-LAMBERT COMPANY (US) 2000-11-02 EP disclosed
EP-1028716-A1 METHOD FOR TREATING AND PREVENTING HEART FAILURE AND VENTRICULAR DILATATION WARNER-LAMBERT COMPANY (US) 2000-08-23 EP disclosed
WO-2000004892-A2 COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS WARNER-LAMBERT COMPANY (US) 2000-02-03 WO disclosed
WO-1999032150-A1 ACE INHIBITOR-MMP INHIBITOR COMBINATIONS WARNER-LAMBERT COMPANY (US) 1999-07-01 WO disclosed
WO-1998025597-A2 METHOD FOR TREATING AND PREVENTING HEART FAILURE AND VENTRICULAR DILATATION WARNER-LAMBERT COMPANY (US) 1998-06-18 WO disclosed
US-5672583-A Carboxy-peptidyl derivatives as antidegenerative active agents MERCK & CO., INC. (US) 1997-09-30 US disclosed
EP-0671911-A4 CARBOXY-PEPTIDYL DERIVATIVES AS ANTIDEGENERATIVE ACTIVE AGENTS. MERCK & CO INC (US) 1996-08-21 EP disclosed
EP-0671911-A1 CARBOXY-PEPTIDYL DERIVATIVES AS ANTIDEGENERATIVE ACTIVE AGENTS MERCK & CO. INC. (US) 1995-09-20 EP disclosed
WO-1994012169-A1 CARBOXY-PEPTIDYL DERIVATIVES AS ANTIDEGENERATIVE ACTIVE AGENTS MERCK & CO., INC. (US) 1994-06-09 WO disclosed